Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose rosuvastatin in acute ST-elevation myocardial infarction undergoing angioplasty
ACTRN12613000032752Phase 4Withdrawn
- Sponsor
- South Australian Health and Medical Research Institute
- Start
- Feb 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in myocardial infarction (MI) comparing High-dose rosuvastatin with Placebo then rosuvastatin 20 mg (2 arms). Primary endpoint: Myocardial infarction size. Planned start Feb 2013; status: withdrawn.
02
Drugs
rosuvastatin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ACTRN12613000032752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000032752.